CONNECT WITH US
HealthTech

HealthTech

Novant COO tapped to lead system after CEO retires

Healthcare Dive logo

Published on

Add as a preferred source on Google
Novant COO tapped to lead system after CEO retires

John Gizdic will serve as Novant Health’s interim chief executive when the health system’s current CEO, Carl Armato, retires at the end of the year.

Gizdic will step up as acting head of Novant following the retirement of current president and CEO Carl Armato at the end of this year.

Gizdic has served as the nonprofit system’s COO since May 2024, after three years as its chief administrative officer. However, Gizdic’s experience with the health system spans more than 20 years, according to Novant’s Tuesday press release on the leadership transition. That includes 15 years at New Hanover Regional Medical Center, which Novant acquired in 2021.

Novant’s board unanimously decided that Gizdic was the right choice to lead the organization through its CEO transition, according to a statement from Christine Katziff, the chair of Novant’s board. Katziff cited Gizdic’s “operational excellence, strategic vision, hands-on experience, and deep industry expertise.”

Armato will pass the reins on Jan. 1 after nearly three decades at Novant Health, half of which he served as president and CEO. During Armato’s tenure as chief executive, the Winston-Salem, N.C.-based health system grew from $3.5 billion in annual operating revenue to nearly $12 billion, and swelled its net assets from $2.2 billion to $8.2 billion.

However, rising expenses continue to put downward pressure on Novant, prompting it to cut retirement benefits for its employees . Novant also blamed its outsized reliance on Medicare and Medicaid, insurance programs that providers say pay well below the actual cost of care.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.